K Number
K080813
Device Name
PRESSUREWIRE CERTUS, CERTUS (300CM), AERIS, AERIS (300CM), RECEIVER
Date Cleared
2008-07-01

(102 days)

Product Code
Regulation Number
870.2870
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
PressureWire® is indicated to direct a catheter through a blood vessel and to measure physiological parameters in the heart and in the coronary and peripheral blood vessel.
Device Description
PressureWire® is a .014" guidewire with an integrated pressure and temperature sensor. together with a detachable cable or transmitter/receiver for connection to a diagnostic computer or a cathlab hemodynamic recording system.
More Information

No
The summary describes a guidewire with sensors for measuring physiological parameters and connecting to existing systems. There is no mention of AI, ML, image processing, or any other technology typically associated with AI/ML functionality. The performance studies focus on functional and safety testing, not algorithmic performance.

No
The device is used to direct a catheter and measure physiological parameters, which are diagnostic functions, not therapeutic.

Yes

The device "measure[s] physiological parameters in the heart and in the coronary and peripheral blood vessel" and connects to a "diagnostic computer." Measuring physiological parameters often serves as a diagnostic function.

No

The device description explicitly states it is a ".014" guidewire with an integrated pressure and temperature sensor," which are hardware components.

Based on the provided information, the PressureWire® is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
  • PressureWire® Function: The PressureWire® is a device that is inserted into the body (specifically blood vessels) to measure physiological parameters in vivo (within a living organism). It is used to guide a catheter and measure pressure and temperature directly within the blood vessels.

Therefore, the PressureWire® is an invasive medical device used for in vivo measurement, not an in vitro diagnostic test.

N/A

Intended Use / Indications for Use

PressureWire® is indicated to direct a catheter through a blood vessel and to measure physiological parameters in the heart and in the coronary and peripheral blood vessel.

Product codes

DXO, DQX

Device Description

PressureWire® is a .014" guidewire with an integrated pressure and temperature sensor. together with a detachable cable or transmitter/receiver for connection to a diagnostic computer or a cathlab hemodynamic recording system.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Heart, coronary and peripheral blood vessel.

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Electrical safety, EMC, radio, sterilization and performance testing indicate that PressureWire® satisfies safety and performance requirements of the device specifications and do not raise additional safety issues.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K062769, K972793, K053016, K883651

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 870.2870 Catheter tip pressure transducer.

(a)
Identification. A catheter tip pressure transducer is a device incorporated into the distal end of a catheter. When placed in the bloodstream, its mechanical or electrical properties change in relation to changes in blood pressure. These changes are transmitted to accessory equipment for processing.(b)
Classification. Class II (performance standards).

0

K080813

JUL - 1 2008

510(k) Summary 5.

This 510(k) summary of safety and effectiveness information is submitted in accordance with the requirements in the Safe Medical Device Act 1990 and 21 CFR §807.92

| Submitted by: | Radi Medical Systems AB
Palmbladsgatan 10
SE-754 50 Uppsala, Sweden
Phone:(+46) 18161000 |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person: | Björn Palmgren |
| Date Prepared: | June 10, 2008 |
| Proprietary Name: | Pressure Wire® |
| Common Name: | Pressure Guidewire |
| Classification Name: | Transducer, Pressure, Catheter Tip (870.2870)
Wire, Guide, catheter (870.1330)
Transmitters and receivers, physiological signal, radiofrequency
(870.2910)
Diagnostic intravascular catheter. (870.1200) |
| Predicate Devices: | PressureWire® (K062769)
PressureWire® System (K972793)
Wireless Physiologic Monitoring System (K053016)
Mikro-Tip Catheter Pressure Transducer (K883651) |

Description of the Device:

PressureWire® is a .014" guidewire with an integrated pressure and temperature sensor. together with a detachable cable or transmitter/receiver for connection to a diagnostic computer or a cathlab hemodynamic recording system.

Intended Use of the Device:

PressureWire® is designed to fit inside a percutaneous catheter for the purpose of directing the catheter through a vessel. The signal output from the senor is used for calculation and presentation of any physiological parameters, functions or indices based on temperature or pressure, e.g. Fractional Flow Reserve (FFR). The indication has been modified to address that the device is not only suitable for usage within peripheral and coronary vessels but also for intracardiac measurements within the actual heart.

Indication for Use of the Device:

Pressure Wire® is indicated to direct a catheter through a blood vessel and to measure physiological parameters in the heart and in the coronary and peripheral blood vessel.

Technical Characteristics:

The guidewire part of subject device is identical to the predicate device (K062769).

The new version PressureWire® Aeris, transfer the signal using frequency hoping in the 2.4 GHz frequency radio band, instead of cable. The output from the PressureWire Receiver is compliant with the ANSI/AAMI BP22 standard.

1

Functional/Safety Testing:

Electrical safety, EMC, radio, sterilization and performance testing indicate that PressureWire® satisfies safety and performance requirements of the device specifications and do not raise additional safety issues.

Conclusion:

On the basis of the testing conducted, it may be concluded that PressureWire® satisfies specified safety and performance requirements. PressureWire® is substantially equivalent to the predicate devices.

2

Image /page/2/Picture/1 description: The image shows the seal of the U.S. Department of Health and Human Services. The seal features a stylized eagle with three lines representing its wings and body. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JUL - 1 2008

Radi Medical Systems AB c/o Mr. Björn Palmgren Regulatory Affairs Officer Palmbladsgatan 10 SE-75450 Uppsala SWEDEN

Re: K080813

Trade Name: PressureWire® Aeris and PressureWire® Receiver Regulation Number: 21 CFR 870.2870 Regulation Name: Catheter Tip Pressure Transducer Regulatory Class: Class II Product Code: DXO and DQX Dated: June 9, 2008 Received: June 11, 2008

Dear Mr. Palmgren:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act

3

Page 2 - Mr. Björn Palmgren

or any Fedcral statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours.

Ashley B. Bran

for

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

Indications for Use

510(k) Number:

K080813

Device Name:

PressureWire®

Indications for Use:

PressureWire® is indicated to direct a catheter through a blood vessel and to measure physiological parameters in the heart and in the coronary and peripheral blood vessel.

Prescription Use______________________________________________________________________________________________________________________________________________________________ X (Per 21 CFR 801.Subpart D) AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)


Devices

Page 1 of 1 -